← Leaderboards
Christopher C Striebich
University Of Colorado Denver
$18,204
Attributed
$18,204
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.8K · FY2005–08$10K$7.5K$5K$2.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$18,204 · 3
By mechanism
M01$18,204 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- V Michael Holers$38,234,826
- Marian J. Rewers$53,889,410
- George S Eisenbarth$13,354,570
- Roberta Pelanda$15,844,961
- Donald Ym Leung$75,548,590
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAlanylalanineArthritisArthritis, PsoriaticInflammatoryInstitutionLeukocytesMonoclonal AntibodiesPharmaceutical PreparationsPsoriasisResearch PersonnelResourcesSafetySkin DisorderSourceSwellingT-LymphocyteUnited States National Institutes Of HealthBinding (Molecular Function)ChronicComputer Retrieval Of Information On Scientific Projects DatabaseEffectivenessFundingGrant
Grant awards (4)
TREATMENT OF PSORIATIC ARTHRITIS WITH HOKT3Y1 (ALA-ALA)$1,028
M01 · FY2008 · RR · contact PI
TREATMENT OF PSORIATIC ARTHRITIS WITH HOKT3Y1 (ALA-ALA)$8,752
M01 · FY2007 · RR · contact PI
STUDY OF AN ANTIBODY FOR ANTI-B CELL THRPY IN TRTMNT OF SYSTMC LUPUS ERYTHMATOSU$2,573
M01 · FY2005 · RR
Study of Antibody for Anti-B Cell Therapy in Tx of SLE$5,851
M01 · FY2004 · RR